Product Details for: Briumvi

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
150MG/6ML (25MG/ML)
Single-Dose Vial
351(a)
Briumvi
Rx
Proper Name
ublituximab-xiiy
BLA Number
761238
Applicant
TG Therapeutics, Inc.
Original Approval Date
December 28, 2022
Date of First Licensure
RETURN TO SEARCH RESULTS